Yep. The conflict of interest is mindblowing, yet no one (such as ASX or ASIC) seem to care. They're too busy trying to take out ASX's nemesis, ISX.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%